SCHEMBL3236359

SCHEMBL3236359

CC(C)CSc1ccc2c(c1)CCN2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.45
DRD4 P21917 1/20 0.45
ALDH1A1 P00352 4/20 0.36
GAA P10253 2/20 0.36
MAPT P10636 2/20 0.36
ALOX15 P16050 2/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
THRB P10828 1/20 0.36
CASP1 P29466 1/20 0.36
HTT P42858 1/20 0.36
CASP7 P55210 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GFER P55789 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
ATM Q13315 1/20 0.34
TSHR P16473 1/20 0.34
S1PR1 P21453 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3245294 0.82 DRD2 (0.49) DRD2DRD4ALDH1A1GAAMAPT
SCHEMBL3231505 0.79 DRD2 (0.46) DRD2DRD4ALDH1A1GAAMAPT
SCHEMBL3238417 0.79 DRD2 (0.49) DRD2DRD4ALDH1A1GAAMAPT
SCHEMBL288350 0.76 DRD2 (0.53) DRD2DRD4ALDH1A1GAAMAPT
SCHEMBL288292 0.76 DRD2 (0.50) DRD2DRD4ALDH1A1GAAMAPT
SCHEMBL8526813 0.76 DRD2 (0.57) DRD2DRD4ALDH1A1GAAMAPT
SCHEMBL3244192 0.75 DRD2 (0.45) DRD2DRD4ALDH1A1GAAMAPT
SCHEMBL3238873 0.74 DRD2 (0.44) DRD2DRD4ALDH1A1GAAMAPT
SCHEMBL31539406 0.74 MAOA (0.46) DRD2DRD4ALDH1A1HSD17B10ATM
SCHEMBL27265657 0.73 DRD2 (0.53) DRD2DRD4ALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2210886-B1 PYRIMIDYL INDOLINE COMPOUND DAIICHI SANKYO CO LTD (JP) 2015-09-23 EP disclosed
CN-101896481-B Pyrimidyl indoline compound DAIICHI SANKYO CO LTD 2014-04-30 CN disclosed
US-8232287-B2 Pyrimidyl indoline compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-07-31 US disclosed
CN-101896481-A Pyrimidyl indoline compound DAIICHI SANKYO CO LTD 2010-11-24 CN disclosed
US-20100292259-A1 PYRIMIDYL INDOLINE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-11-18 US disclosed
EP-2210886-A1 PYRIMIDYL INDOLINE COMPOUND Daiichi Sankyo Company, Limited (JP) 2010-07-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292259-A1 PYRIMIDYL INDOLINE COMPOUND GPR119, SLC5A2, SLC5A1 DRD2 1855/4885DRD4 614/4885ALDH1A1 1197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.